Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Avalanche Biotechnologies
1555 Adams Drive, Suite A
Menlo Park, CA 94025
Phone: 650-735-1324
www.avalanchebiotech.com

Founded in 2006, Avalanche Biotechnologies, Inc., is a privately held, clinical-stage biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins. Avalanche's lead product, AVA-101, is currently under development in a Phase 2a trial for wet age-related macular degeneration. Avalanche's BioFactoryTM platform technology is a proprietary adeno-associated virus (AAV)-based gene therapy discovery and development technology optimized for ophthalmology that utilizes a directed evolution approach to generate novel drug candidates.

Key Contact
Name
Thomas Chalberg
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
04/22/14 $55,000,000 Series B Adage Capital Partners
Deerfield Partners
Redmile Group
Rock Springs Capital
Sabby Capital
Venrock
undisclosed


Featured Reading